ETCTN Phase 1 Trial of Gemcitabine Combined with the BAY 1895344 ATR Inhibitor with Expansion Cohorts in Advanced Pancreatic and Ovarian Cancer Adult CIRB - Early Phase Emphasis Active Available to Open